Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 4 results for "dusa pharmaceuticals"

Morgan Stanley rates Sun Pharmaceutical Industries Equal-Weight
Financial Express

Morgan Stanley rates Sun Pharmaceutical Industries Equal-Weight

Sun continues to bolster its specialty pipeline—Tildrakizumab (Merck), Odomzo (Novartis), MM-II (Moebius), Seciera (Ocular), Elepsia/Xelpros (SPARC), BromSite/DexaSite (Insite), Absorica (Ranbaxy), and Dusa drug products. Sun announced that its ... Financial Express, 1 week ago

1 images for "dusa pharmaceuticals"

Financial Express, 1 week ago

A Light Boost

Photodynamic therapy (PDT), the practice of irradiating a photosensitizing agent to damage cells, has a broad—and growing—range of indications. In dermatology, PDT is used to target precancerous and cancerous lesions, reduce the redness of ...
 MedEsthetics Magazine4 days ago

Research and Markets - Global Actinic Keratosis Market Analysis - Trends, Technologies & Opportunities Report..

/PRNewswire/ -- Research and Markets has announced the addition of the "Global Actinic Keratosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2012 To 2022" ...
 ADVFN India2 months ago Global Actinic Keratosis Market Report 2012-2022 - Analysis, Technologies & Forecasts - Vendors: Apotex, Perrigo Company, Tolmar Pharmaceuticals - Research and Markets  PharmiWeb2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less